Grant: Engage Grants Program
University of Toronto
$25,000.00
Accelerated erasure of a selenium based X-ray imaging system
EF 2015-16
Résumé
It is estimated that worldwide approximately 1.7 million women are diagnosed with breast cancer per year.
Mammography is the gold standard for detection of this disease. In countries where breast cancer screening
with mammography is not commonly practised, cancers are more frequently detected when they are already at
an advanced stage and prognosis is poor. XLV Diagnostics Inc. was created to develop a low cost
mammography system to expand the reach of mammography screening. XLV's technology will be attractive in
emerging markets, such as China, India and Brazil, where breast cancer cases are outpacing access to image
based diagnostic technology, as well as in low resources areas within Canada. This low cost high resolution
technology may also prove useful in future radiologic applications such as extremity imaging and bone fracture
assessment.
XLV digital technology, conceived by Canadian scientists, offers a substantial decrease in cost over traditional
flat panel mammography detectors by eliminating the need for large area transistor arrays and expensive, high
density, low noise electronics. Instead a thin liquid crystal layer is positioned between an amorphous selenium
layer and an optical scanner based on consumer electronics technology. In addition to XLV supplying complete
digital mammography systems, it will also be possible to upgrade existing analogue screen-film units to digital
by replacing the screen-film assembly with modular XLV digital sensors. XLV will be working with
Sunnybrook Research Institute to develop a means to accelerate charge erasure in their selenium based liquid
crystal mammography system, a key limitation in the current design. This will allow high quality mammograms
to be acquired with increased patient throughput. Ultimately, the successful development of this novel
technology can then be applied to the development of other low cost, high resolution, digital x-ray systems.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
485875-2015
Name nom
Whyne, Cari
Department département
Surgery
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3300
Research subject group en
Condensed matterphysics
Research subject group fr
Physique de la matière condensée
Research subject en
Condensed matterphysics
Research subject fr
Physique de la matière condensée
Partie
1
Nb partie
1
Application title
Accelerated erasure of a selenium based X-ray imaging system
Keyword
NSERC
Application summary
It is estimated that worldwide approximately 1.7 million women are diagnosed with breast cancer per year.
Mammography is the gold standard for detection of this disease. In countries where breast cancer screening
with mammography is not commonly practised, cancers are more frequently detected when they are already at
an advanced stage and prognosis is poor. XLV Diagnostics Inc. was created to develop a low cost
mammography system to expand the reach of mammography screening. XLV's technology will be attractive in
emerging markets, such as China, India and Brazil, where breast cancer cases are outpacing access to image
based diagnostic technology, as well as in low resources areas within Canada. This low cost high resolution
technology may also prove useful in future radiologic applications such as extremity imaging and bone fracture
assessment.
XLV digital technology, conceived by Canadian scientists, offers a substantial decrease in cost over traditional
flat panel mammography detectors by eliminating the need for large area transistor arrays and expensive, high
density, low noise electronics. Instead a thin liquid crystal layer is positioned between an amorphous selenium
layer and an optical scanner based on consumer electronics technology. In addition to XLV supplying complete
digital mammography systems, it will also be possible to upgrade existing analogue screen-film units to digital
by replacing the screen-film assembly with modular XLV digital sensors. XLV will be working with
Sunnybrook Research Institute to develop a means to accelerate charge erasure in their selenium based liquid
crystal mammography system, a key limitation in the current design. This will allow high quality mammograms
to be acquired with increased patient throughput. Ultimately, the successful development of this novel
technology can then be applied to the development of other low cost, high resolution, digital x-ray systems.